## Materia licences metathesis catalyst platform to Aileron Therapeutics Materia Inc announced the licensing of its metathesis platform to Aileron Therapeutics, an emerging biopharmaceutical company, for use in the discovery and development of peptide therapeutics directed at intracellular protein-
Novozymes and Broin collaborate in bioethanol production
- Publisher
- Elsevier Science
- Year
- 2006
- Weight
- 43 KB
- Volume
- 2006
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
catalysts business of Nippon Shokubai Co Ltd has reported total sales of Yen 29.32 bn (Yen 23.34 bn for its fiscal 2005), operating income of Yen 2.98 bn (Yen 3.12 bn), and capital investments of Yen 370 M (Yen 394 M). Sales of automotive catalysts increased as surging precious metal pricing increas
## BASF collaborates with Tekion BASF and Tekion will establish an alliance to develop formic acid for use as fuel for the latter's fuel cell technology. The alliance will set codes and standards, develop and test a custom-made formic acid formulation, and handle materials compatibility for fuel c
## Cosmo considers widening use of enhanced FCC process Cosmo Oil is considering rolling out its improved fluid-catalytic-cracking (FCC) technology at all its refineries in Japan. The process uses a proprietary catalyst to remove sulfur from gasoline without lowering the gasoline's octane rating. T
ethanol production. Poet is going against the current trend by building 4-5 plants per year even though ethanol prices are low. Novozymes is investing heavily in developing bioethanol as an alternative to petrol but the company's continued growth in Denmark requires positive developments, especially